Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Renal Function on the Prognosis of Patients Receiving Atezolizumab/Bevacizumab Combination Therapy and Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma.
Takada H, Yamashita K, Osawa L, Komiyama Y, Nakakuki N, Muraoka M, Suzuki Y, Sato M, Takano S, Fukasawa M, Yamaguchi T, Maekawa S, Takahashi K, Uchimura K, Enomoto N. Takada H, et al. Among authors: nakakuki n. Oncology. 2023;101(10):609-623. doi: 10.1159/000531111. Epub 2023 Jun 6. Oncology. 2023. PMID: 37279708
Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
Takada H, Tsuchiya K, Yasui Y, Nakakuki N, Tamaki N, Suzuki S, Nakanishi H, Itakura J, Takahashi Y, Kurosaki M, Asahina Y, Enomoto N, Izumi N. Takada H, et al. Among authors: nakakuki n. Cancer Med. 2016 Nov;5(11):3111-3120. doi: 10.1002/cam4.932. Epub 2016 Oct 17. Cancer Med. 2016. PMID: 27748052 Free PMC article.
Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment.
Nakanishi H, Kurosaki M, Tsuchiya K, Yasui Y, Higuchi M, Yoshida T, Komiyama Y, Takaura K, Hayashi T, Kuwabara K, Nakakuki N, Takada H, Ueda M, Tamaki N, Suzuki S, Itakura J, Takahashi Y, Izumi N. Nakanishi H, et al. Among authors: nakakuki n. Liver Cancer. 2016 Oct;5(4):257-268. doi: 10.1159/000449337. Epub 2016 Sep 14. Liver Cancer. 2016. PMID: 27781198 Free PMC article.
Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C.
Maekawa S, Sato M, Kuratomi N, Inoue T, Suzuki Y, Tatsumi A, Miura M, Matsuda S, Muraoka M, Nakakuki N, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Sato T, Sakamoto M, Murakawa M, Nakagawa M, Asahina Y, Enomoto N. Maekawa S, et al. Among authors: nakakuki n. J Gastroenterol. 2018 Jun;53(6):780-786. doi: 10.1007/s00535-017-1405-3. Epub 2017 Nov 1. J Gastroenterol. 2018. PMID: 29094205
Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinoma.
Suzuki Y, Maekawa S, Komatsu N, Sato M, Tatsumi A, Miura M, Matsuda S, Muraoka M, Nakakuki N, Shindo H, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Inoue T, Sato T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N. Suzuki Y, et al. Among authors: nakakuki n. Hepatol Res. 2019 Jan;49(1):51-63. doi: 10.1111/hepr.13277. Epub 2018 Dec 27. Hepatol Res. 2019. PMID: 30350374
HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers.
Suzuki Y, Maekawa S, Komatsu N, Sato M, Tatsumi A, Miura M, Matsuda S, Muraoka M, Nakakuki N, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Inoue T, Sato T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N. Suzuki Y, et al. Among authors: nakakuki n. PLoS One. 2019 Feb 22;14(2):e0212559. doi: 10.1371/journal.pone.0212559. eCollection 2019. PLoS One. 2019. PMID: 30794632 Free PMC article.
Cancer-related genetic changes in multistep hepatocarcinogenesis and their correlation with imaging and histological findings.
Muraoka M, Maekawa S, Suzuki Y, Sato M, Tatsumi A, Matsuda S, Miura M, Nakakuki N, Shindo H, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Inoue T, Sato T, Yamashita A, Moriishi K, Matsuda M, Enomoto N. Muraoka M, et al. Among authors: nakakuki n. Hepatol Res. 2020 Sep;50(9):1071-1082. doi: 10.1111/hepr.13529. Epub 2020 Jun 30. Hepatol Res. 2020. PMID: 32510681
Deep sequencing analysis of serum hepatitis B virus-RNA during nucleot(s)ide analogue therapy.
Matsuda S, Maekawa S, Komiyama Y, Nakakuki N, Muraoka M, Suzuki Y, Sato M, Tatsumi A, Miura M, Amemiya F, Shindo H, Takano S, Fukasawa M, Yamaguchi T, Nakayama Y, Inoue T, Sato T, Yamashita A, Moriishi K, Enomoto N. Matsuda S, et al. Among authors: nakakuki n. Hepatol Res. 2021 Jan;51(1):39-50. doi: 10.1111/hepr.13574. Epub 2021 Jan 11. Hepatol Res. 2021. PMID: 32961003
MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing.
Kuratomi N, Takano S, Fukasawa M, Maekawa S, Kadokura M, Shindo H, Takahashi E, Hirose S, Fukasawa Y, Kawakami S, Hayakawa H, Takada H, Nakakuki N, Kato R, Yamaguchi T, Nakayama Y, Kawaida H, Kono H, Inoue T, Kondo T, Ichikawa D, Enomoto N. Kuratomi N, et al. Among authors: nakakuki n. Int J Mol Sci. 2021 Mar 22;22(6):3221. doi: 10.3390/ijms22063221. Int J Mol Sci. 2021. PMID: 33809988 Free PMC article.
Usefulness of Cell-Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment Efficacy.
Muraoka M, Maekawa S, Katoh R, Komiyama Y, Nakakuki N, Takada H, Matsuda S, Suzuki Y, Sato M, Tatsumi A, Miura M, Amemiya F, Shindo H, Takano S, Fukasawa M, Yamauchi K, Yamaguchi T, Nakayama Y, Inoue T, Enomoto N. Muraoka M, et al. Among authors: nakakuki n. Hepatol Commun. 2021 Nov;5(11):1927-1938. doi: 10.1002/hep4.1762. Epub 2021 Jul 28. Hepatol Commun. 2021. PMID: 34558819 Free PMC article.
27 results